Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA‐AF Registry Phase III
Journal of the American Heart Association · 17.03.2026 · 15 (6)
DOI: 10.1161/jaha.125.044293 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 17.03.2026. Verfasst von Bernadette Corica und 8 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool Liverpool John Moores University and Liverpool Heart and Chest Hospital Liverp…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anti-Arrhythmia Agents, Anticoagulants, Heart Rate. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Early rhythm control has been proposed to improve outcomes in patients with atrial fibrillation (AF), but data on its effectiveness in real‐world cohorts remain limited. We aimed to evaluate the effectiveness of rhythm control in patients with recently diagnosed AF.
Methods
We included patients with recently diagnosed AF enrolled in the GLORIA‐AF (Global Registry on Long‐Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) registry phase III. We analyzed rhythm control at baseline, defined as treatment with an antiarrhythmic drug, or having received AF ablation or cardioversion; patients who did not receive any of these treatments were assigned to the “no rhythm control” group. We analyzed factors associated with rhythm control, treatment with an oral anticoagulant, and risk of major outcomes using multivariable regression analyses. The primary outcome for this analysis was the composite of all‐cause death and major adverse cardiovascular events.
Results
Of 21 051 patients with AF included in this analysis (mean age, 70.2±10.3 years, 45% women), 6932 (32.9%) received rhythm control. Older age, more sustained forms of AF, and history of thromboembolism were associated with no rhythm control at baseline; conversely, oral anticoagulants were more likely used in patients receiving rhythm control (odds ratio, 1.36 [95% CI, 1.25–1.48]). During 3‐year follow‐up, rhythm control was associated with lower hazard of the primary composite outcome (hazard ratio, 0.88 [95% CI, 0.80–0.96]). Similar results were observed for other secondary outcomes, including all‐cause death, thromboembolism, and major bleeding.
Conclusions
In this real‐world cohort of patients with AF, rhythm control was used in 1 of 3 patients, and was associated with higher use of oral anticoagulants and better outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Liverpool Centre for Cardiovascular Science at University of Liverpool Liverpool John Moores University and Liverpool Heart and Chest Hospital Liverpool UK.
- Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia, Policlinico di Modena Modena Italy.
- Department of Wellbeing, Health and Environmental Sustainability Sapienza-University of Rome Rome Italy.
- Department of Clinical Sciences and Community Health University of Milan Milan Italy.
- Division of Cardiogeriatric Subacute Care IRCCS Istituti Clinici Scientifici Maugeri Milan Italy.
- Division of Cardiology, Department of Internal Medicine University of Iowa Hospitals and Clinics Iowa City IA USA.
ORCID-Profile: Bernadette Corica, Giulio Francesco Romiti, Marco Proietti, Davide Antonio Mei, Giuseppe Boriani, Brian Olshansky, Menno V Huisman, Gregory Y H Lip
Zitieren
APA
Corica, B., Romiti, G. F., Proietti, M., Mei, D. A., Boriani, G., Olshansky, B., Huisman, M. V., Lip, G. Y. H., & GLORIA‐AF Investigators (2026). Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA‐AF Registry Phase III. Journal of the American Heart Association, 15(6). https://doi.org/10.1161/jaha.125.044293
Vancouver
Corica B, Romiti GF, Proietti M, Mei DA, Boriani G, Olshansky B, et al. Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA‐AF Registry Phase III. Journal of the American Heart Association. 2026;15(6). doi:10.1161/jaha.125.044293
BibTeX
@article{Corica2026,
author = {Corica, Bernadette and Romiti, Giulio Francesco and Proietti, Marco and Mei, Davide Antonio and Boriani, Giuseppe and Olshansky, Brian and Huisman, Menno V and Lip, Gregory Y H and GLORIA‐AF Investigators, GLORIA‐AF Investigators},
title = {Rhythm Control in Patients With Recently Diagnosed Atrial Fibrillation: Findings From the GLORIA‐AF Registry Phase III},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {6},
doi = {10.1161/jaha.125.044293}
}
EUVIMED